Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

719 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Comparison of haploidentical hematopoietic stem cell transplantation and matched-sibling donor transplantation for the treatment of paroxysmal nocturnal hemoglobinuria].
Liu LM, Zhou HF, Wang QY, Qiu HY, Tang XW, Han Y, Fu CC, Jin ZM, Chen SN, Sun AN, Miao M, Wu DP. Liu LM, et al. Zhonghua Xue Ye Xue Za Zhi. 2019 Apr 14;40(4):306-311. doi: 10.3760/cma.j.issn.0253-2727.2019.04.008. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31104442 Free PMC article. Chinese.
[Outcomes of allogeneic hematopoietic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria compared to paroxysmal nocturnal hemoglobinuria-aplastic anemia syndrome].
Liu LM, Zhou HF, Wang QY, Qiu HY, Tang XW, Han Y, Fu CC, Jin ZM, Chen SN, Sun AN, Miao M, Wu DP. Liu LM, et al. Zhonghua Xue Ye Xue Za Zhi. 2019 Jun 14;40(6):472-476. doi: 10.3760/cma.j.issn.0253-2727.2019.06.005. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31340619 Free PMC article. Chinese.
Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients.
Ma Y, Dai H, Cui Q, Liu S, Kang L, Lian X, Cui W, Yin J, Liu L, Cai M, Yu L, Wu D, Tang X. Ma Y, et al. Exp Hematol Oncol. 2023 Apr 10;12(1):36. doi: 10.1186/s40164-023-00397-z. Exp Hematol Oncol. 2023. PMID: 37038230 Free PMC article.
Corrigendum to "Isopropyl 3-(3, 4-dihydroxyphenyl)-2-hydroxypropanoate protects lipopolysaccharide-induced acute lung injury in mice by attenuating pyroptosis" [Eur. J. Pharmacol. 5 (2023) 175545].
Zhang ML, Wang M, Chen J, Liu YJ, Yu YJ, Liu LM, Zheng XH, Xiao YC, Zhang JM, Zhu MX, Yue X, Zhao Y, Niu W, Li ZC. Zhang ML, et al. Among authors: liu lm. Eur J Pharmacol. 2025 Jan 22:177287. doi: 10.1016/j.ejphar.2025.177287. Online ahead of print. Eur J Pharmacol. 2025. PMID: 39848814 No abstract available.
[Comparison of the efficacy and safety between high-dose intravenous iron and oral iron in treating iron deficiency anemia: a multicenter, prospective, open-label, randomized controlled study].
Zhang Q, Wang H, Zhang YM, Li XL, Shen YY, Wei N, Zou K, Su WX, Dai HP, Wu DP, Liu LM. Zhang Q, et al. Among authors: liu lm. Zhonghua Xue Ye Xue Za Zhi. 2024 Dec 14;45(12):1113-1118. doi: 10.3760/cma.j.cn121090-20240424-00161. Zhonghua Xue Ye Xue Za Zhi. 2024. PMID: 39765352 Clinical Trial. Chinese.
719 results